在注射肉毒素后,过渡性双边肌病的古怪表现:一个病例报告
Rana Alhumaemydi1, Abeer Alkhodier2, Ismail Alghamdi1
1Department of Ophthalmology, College of Medicine, King Saud University (KSU), Riyadh, Saudi Arabia; Department of Ophthalmology, King Saud University Medical City (KSUMC), Riyadh, Saudi Arabia.
International journal of surgery case reports
|March 9, 2025
概括
毒素 (Botox) 注射用于可以导致儿童的过渡性脑膜炎 (瞳孔扩张). 这一案例凸显了监测这种潜在副作用的重要性,即使剂量不同.
科学领域:
- 眼科医生 眼科 眼科
- 神经毒素是一种神经毒素.
- 儿科医学 儿科医学
背景情况:
- 毒素 (Botox) 通过通过释放乙胆诱导肌肉麻,对是有效的.
- 眼或瞳孔膨胀是眼科中博托克斯治疗的已知的潜在并发症.
- 脑膜炎可以是暂时的或持久的.
研究的目的:
- 在儿童中注射博托克斯后报告过渡性双边肌病的病例,该病例患有食otropia和下斜肌过度运动.
- 讨论这种不良事件的潜在机制和临床影响.
主要方法:
- 一个病例报告,一个4岁的孩子患有食otropia和下斜肌过度活动.
- 患者接受了博托克斯注射治疗.
- 注射后监测不良影响,特别是瞳孔变化.
主要成果:
- 患者在注射Botox后出现过渡性双边肌病.
- 随后的更高剂量的博托克斯并没有导致肌,这表明了潜在的患者特异性变化.
- 不良影响的确切机制尚不清楚,假设涉及毒素扩散到附近的结构.
结论:
- 博托克斯在儿科眼科中是一种有价值的治疗方法,但过渡性脑膜炎是一种可能的副作用.
- 在这种情况下,无论剂量如何,肌病的发生都需要进一步研究潜在的机制.
- 注射后的警监测对于管理潜在的并发症至关重要,如肌.
相关概念视频
Skeletal Muscle Relaxants: Therapeutic Uses
452
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
452
Direct-Acting Cholinergic Agonists: Therapeutic Uses
663
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
663
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
642
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
642
Depolarizing Blockers: Pharmocokinetics
299
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
299
Skeletal Muscle Relaxants: Adverse Effects
327
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
327
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
383
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
383


